We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Director Non-Statutory Stock Option Agreement Sample Contracts

Standard Contracts

PROTO LABS, INC. Director Non-Statutory Stock Option Agreement
Director Non-Statutory Stock Option Agreement • August 30th, 2022 • Proto Labs Inc • Fabricated structural metal products • Minnesota

Proto Labs, Inc. (the “Company”), pursuant to its 2022 Long-Term Incentive Plan (the “Plan”), hereby grants to you, the Optionee named below, an Option to purchase the number of shares of the Company’s common stock shown in the table below at the specified exercise price per share. The terms and conditions of this Option Award are set forth in this Agreement, consisting of this cover page and the Option Terms and Conditions on the following pages, and in the Plan document which is attached. To the extent any capitalized term used in this Agreement is not defined, it shall have the meaning assigned to it in the Plan as it currently exists or as it is amended in the future.

the l.s. starrett company Director Non-statutory Stock Option Agreement
Director Non-Statutory Stock Option Agreement • February 7th, 2013 • Starrett L S Co • Cutlery, handtools & general hardware • Massachusetts

This agreement (the “Agreement”) evidences a stock option granted by The L.S. Starrett Company (the “Company”) to the undersigned (the “Optionee”), pursuant to and subject to the terms of The L.S. Starrett Company 2012 Long-Term Incentive Plan (as amended from time to time, the “Plan”), which is incorporated herein by reference.

FORM OF INSPIRE PHARMACEUTICALS, INC. DIRECTOR NON-STATUTORY STOCK OPTION AGREEMENT
Director Non-Statutory Stock Option Agreement • August 11th, 2003 • Inspire Pharmaceuticals Inc • Pharmaceutical preparations

Inspire Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, as an incentive and inducement to (the “Optionee”), who is presently a member of the Board of Directors of the Company (the “Board”) [and a member of the audit committee of the Board (the “Audit Committee”)], to devote his or her best efforts to the affairs of the Company, which incentive and inducement the Board has determined to be sufficient consideration for the grant of this option, hereby grants to the Optionee the right and option (the “Option”) to purchase shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”) under the following terms:

CIVITAS THERAPEUTICS, INC. DIRECTOR NON-STATUTORY STOCK OPTION AGREEMENT
Director Non-Statutory Stock Option Agreement • September 15th, 2014 • Civitas Therapeutics, Inc. • Biological products, (no disgnostic substances)

This agreement (this “Agreement”) evidences a stock option granted by Civitas Therapeutics, Inc. (the “Company”) to the undersigned (the “Optionee”) pursuant to and subject to the terms of the Civitas Therapeutics, Inc. 2014 Equity Incentive Plan (as amended from time to time, the “Plan”).